{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:12:19Z","timestamp":1787314339693,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Emer Care"],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Urgent medical evaluation is recommended for patients with sickle cell disease (SCD) and fever. Clear recommendations exist regarding certain aspects of treatment, but other areas lack evidence. We determined practice variation for children with SCD presenting with fever to the emergency department (ED).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective chart review of children ages 3 months to 21 years with SCD presenting to the ED with fever greater than or equal to 38.5\u00b0C in the ED or preceding 24 hours. Visits from 3 sickle cell centers were included. Outcomes included blood culture, complete blood count, antibiotic treatment, chest x-ray, urinalysis, electrolytes, and hospital disposition. Differences greater than 10% were considered clinically meaningful.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The population included 14,454 visits, of which 4143 (29%) were febrile and met all inclusion criteria. A complete blood count and blood culture were obtained at 94% of visits, and antibiotics were given at 91%, with no differences among sites. Meaningful differences existed for disposition, with 52%, 43%, and 99% of patients admitted to the inpatient units at hospitals A, B, and C, respectively. Differences were seen in obtaining a urinalysis (33%, 17%, and 21%), electrolytes (2%, 50%, and 12%), and chest x-rays for patients 2 years and older (78%, 77%, 64%) for hospitals A, B, and C, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Significant variation exists in the proportion of children who receive a urinalysis, electrolytes, chest x-ray, and, most importantly, admission to the hospital. These examples of practice variation represent potential opportunities to define best care practices for children with SCD presenting to the ED for fever.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/pec.0000000000001569","type":"journal-article","created":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T18:31:29Z","timestamp":1531765889000},"page":"574-577","source":"Crossref","is-referenced-by-count":12,"title":["Practice Variation in Emergency Department Management of Children With Sickle Cell Disease Who Present With Fever"],"prefix":"10.1097","volume":"34","author":[{"given":"Katherine","family":"Eisenbrown","sequence":"first","affiliation":[{"name":"School of Medicine, Medical College of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Ellison","sequence":"additional","affiliation":[{"name":"Pediatric Emergency Medicine, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Nimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwakemi","family":"Badaki-Makun","sequence":"additional","affiliation":[{"name":"Pediatric Emergency Medicine, Department of Pediatrics, Johns Hopkins University, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Brousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20230930","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","year":"2010","journal-title":"Lancet"},{"issue":"4S","key":"bib2-20230930","first-page":"S512","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","year":"2010","journal-title":"Am J Prev Med"},{"key":"bib3-20230930","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajh.21570","article-title":"The number of people with sickle-cell disease in the United States: national and state estimates","volume":"85","year":"2010","journal-title":"Am J Hematol"},{"key":"bib4-20230930","first-page":"579","article-title":"Bacteremia in sickle hemoglobinopathies","volume":"109","year":"1989","journal-title":"J Pediatr"},{"key":"bib5-20230930","first-page":"37","article-title":"National Heart, Lung, and Blood Institute","volume":"2014","year":"2014","journal-title":"Evidence-based management of sickle cell disease, expert panel report"},{"key":"bib6-20230930","first-page":"1","article-title":"Variation in pediatric emergency department care of sickle cell disease and fever","volume":"22","year":"2015","journal-title":"Acad Emerg Med"},{"key":"bib7-20230930","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/pbc.25432","article-title":"The accuracy of using ICD-9-CM codes to determine genotype and fever status of patients with sickle cell disease","volume":"62","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"bib8-20230930","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1067\/S0022-3476(03)00331-7","article-title":"Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance and 23 valent pneumococcal polysaccharide vaccination","volume":"143","year":"2003","journal-title":"J Pediatr"},{"key":"bib9-20230930","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1542\/peds.2007-0018","article-title":"Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life","volume":"121","year":"2008","journal-title":"Pediatrics"},{"key":"bib10-20230930","first-page":"650","article-title":"Epidemiology of blood stream infections in children with sickle cell disease","volume":"32","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"bib11-20230930","first-page":"534","article-title":"Pneumococcal bacteremia in a vaccinated pediatric sickle cell disease population","volume":"31","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"bib12-20230930","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpeds.2010.11.025","article-title":"Increase in invasive Streptococcus pneumoniae infections in children with sickle cell disease since pneumococcal conjugate vaccine licensure","volume":"158","year":"2011","journal-title":"J Pediatr"},{"key":"bib13-20230930","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0196-0644(99)70273-8","article-title":"Clinician assessment for acute chest syndrome in febrile patients with sickle cell disease: is it accurate enough?","volume":"34","year":"1999","journal-title":"Ann Emerg Med"},{"key":"bib14-20230930","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJM199308123290705","article-title":"A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell disease","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"bib15-20230930","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1542\/peds.2012-2139","article-title":"Bacteremia risk and outpatient management of febrile patients with sickle cell disease","volume":"131","year":"2013","journal-title":"Pediatrics"},{"key":"bib16-20230930","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0022-3476(05)80591-8","article-title":"Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone","volume":"120","year":"1992","journal-title":"J Pediatr"},{"key":"bib17-20230930","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/archpedi.154.4.386","article-title":"Clinical decision rule to identify febrile young girls at risk for urinary tract infection","volume":"154","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"bib18-20230930","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0196-0644(05)80991-6","article-title":"Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research","volume":"22","year":"1993","journal-title":"Ann Emerg Med"},{"key":"bib19-20230930","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1542\/peds.2013-1820","article-title":"Management of febrile neonates in US pediatric emergency departments","volume":"133","year":"2014","journal-title":"Pediatrics"}],"container-title":["Pediatric Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006565-201808000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T05:01:59Z","timestamp":1720414919000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006565-201808000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/pec.0000000000001569","relation":{},"ISSN":["1535-1815","0749-5161"],"issn-type":[{"value":"1535-1815","type":"electronic"},{"value":"0749-5161","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}